Your browser doesn't support javascript.
loading
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Sokolova, Alexandra O; Marshall, Catherine H; Lozano, Rebeca; Gulati, Roman; Ledet, Elisa M; De Sarkar, Navonil; Grivas, Petros; Higano, Celestia S; Montgomery, Bruce; Nelson, Peter S; Olmos, David; Sokolov, Vadim; Schweizer, Michael T; Yezefski, Todd A; Yu, Evan Y; Paller, Channing J; Sartor, Oliver; Castro, Elena; Antonarakis, Emmanuel S; Cheng, Heather H.
Afiliación
  • Sokolova AO; Division of Medical Oncology, Oregon Health Science University, Portland, Oregon, USA.
  • Marshall CH; Division on Medical Oncology, Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
  • Lozano R; Prostate Cancer Clinical Research Unit, Division on Medical Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gulati R; Division on Medical Oncology, Genitourinary Cancer Traslational Research Group, Instituto de Investigación Biomédica de Málaga, Malaga, Spain.
  • Ledet EM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • De Sarkar N; Systems Engineering and Operations Research Department, George Mason University, Fairfax, Virginia, USA.
  • Grivas P; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Higano CS; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Montgomery B; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Nelson PS; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Olmos D; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Sokolov V; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Schweizer MT; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Yezefski TA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Yu EY; Prostate Cancer Clinical Research Unit, Division on Medical Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Paller CJ; Division on Medical Oncology, Genitourinary Cancer Traslational Research Group, Instituto de Investigación Biomédica de Málaga, Malaga, Spain.
  • Sartor O; Systems Engineering and Operations Research Department, George Mason University, Fairfax, Virginia, USA.
  • Castro E; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Antonarakis ES; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Cheng HH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Prostate ; 81(16): 1382-1389, 2021 12.
Article en En | MEDLINE | ID: mdl-34516663
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Proteína BRCA2 / Administración del Tratamiento Farmacológico / Neoplasias de la Próstata Resistentes a la Castración / Proteínas de la Ataxia Telangiectasia Mutada / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Docetaxel / Androstenos / Nitrilos Tipo de estudio: Observational_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Proteína BRCA2 / Administración del Tratamiento Farmacológico / Neoplasias de la Próstata Resistentes a la Castración / Proteínas de la Ataxia Telangiectasia Mutada / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Docetaxel / Androstenos / Nitrilos Tipo de estudio: Observational_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos